Abnormal antioxidant status in impaired glucose tolerance and noninsulin-dependent diabetes mellitus

Diabetic Medicine

Volumn 13, Issue 8, 1996, Pages 715-719

  Vijayalingam, S ^a   Parthiban, A ^a   Shanmugasundaram, K R ^a   Mohan, V ^b  

^a UNIVERSITY OF MADRAS   (India)

^b MV Diabetes Specialties Center   (India)

Author keywords

Antioxidant enzymes and scavengers; Early hyperglycaemia; Impaired glucose tolerance; Lipid peroxidation; Membrane LPO; NIDDM

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CATALASE; GLUTATHIONE; SUPEROXIDE DISMUTASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; ANTIOXIDANTS; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FEMALE; GLUCOSE INTOLERANCE; GLUTATHIONE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; PEROXIDASES; REFERENCE VALUES; SUPEROXIDE DISMUTASE; VITAMINS;

EID: 0030011235     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199608)13:8<715::AID-DIA172>3.0.CO;2-Z     Document Type: Article

References (26)

1. National Diabetes Data Group. Classification and diagnosis of diabetes and other categories of glucose intolerance. Diabetes 1979; 29: 1039-1057.
2. WHO Expert Committee on Diabetes Mellitus. Diabetes Mellitus. Second Report. Technical Report Series 646. Geneva: World Health Organization, 1980.
3. Jarrett RJ, Keen H, Fuller JH, McCartney M. Worsening to diabetes in men with impaired glucose tolerance ('borderline diabetes'). Diabetologia 1979; 16: 25-30.
4. Ohlson LO, Larsson B, Erikson H, Svardsudd K, Welin L, Tibblin G. Diabetes mellitus in Swedish middle-aged men: the study of men born in 1913 and 1923. Diabetologia 1987; 30: 386-393.
5. Jones AF, Jennings PE, Winkles J, Lunec J, Barnett AH. Impaired serum antioxidant activity in diabetic microangiopathy. Diabetic Med 1985; 2: 502.
6. Baynes JW. Perspectives in diabetes. Role of oxidative stress in development of complication in diabetes. Diabetes 1991; 40: 405-412.
7. Loven DP, Oberley LW. Free radicals, insulin action and diabetes. In: Oberley LW, eds. Superoxide Dismutase Vol. 3. Boca Raton, Florida: CRC Press, 1985; 151-189.
8. Wang J, Yang G. Colorimetric detection of glycosylated haemoglobin in Human. Yixylyna Xuebao 1982; 7: 325-328.
9. Dodge JT, Carolyn M, Donald JH. Preparation and chemical characteristics of haemoglobin free ghosts of human erythrocytes. Arch Biochem Biophys 1963; 100: 199-230.
10. Shanmugasundaram KR, Padmavathi C, Acharya S, Vidhyalakshmi N, Vijayan VK. Exercise induced cholesterol depletion in human red cell membranes. Exp Physiol 1992; 77: 933-936.
11. Yagi K. Simple fluorimetric assay for lipid peroxides in blood plasma. Biochem Med 1976; 15: 212-215.
12. Cyanomon AA, Isenberg JN, Nguyen WH. Erythrocyte malondialdehyde release in vitro: a functional measure of vitamin A status. Clin Chim Acta 1985; 151: 169-176.
13. Rotruck JT, Pope AC, Ganther HE, Swanson AB, Hafeman DG, Hoekstra MG. Selenium: biochemical role as a component of glutathione peroxidase purification and assay. Science 1973; 179: 588-590.
14. Misra HP, Fridovich I. The role of superoxide anion in the auto-oxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972; 247: 3170-3175.
15. Sinha AK. Colorimetric assay of catalase. Anal Biochem 1972; 47: 389-395.
16. Bayfield RF, Cole ER. Colorimetric estimation of vitamin A with trichloroacetic acid. In: McCormick DB, Wought LD, eds. Methods in Enzymology. New York: Academic Press, 1980: 189-195.
17. Emmerie A, Engle C. Colorimetric determination of a-tocopherol. (vitamin E). Rec Tran Chin 1938: 57: 1351-1355.
18. Omaye ST, Turnabull JD, Sauberlich HE. Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids. Methods in Enzymology. New York: Academic Press, 1979: 1-11.
19. Beutler E, Kelley BM. The effect of sodium nitrate on red cell glutathione. Experentia 1963; 19: 96-97.
20. Thomas I, Gupta S, Sempos C, Cooper R. Serum lipids of Indian physicians living in the US compared to the US born physicians. Atherosclerosis 1986; 61: 99-106.
21. Hall PM, Cook JG, Sheldon J, Rutherford SM, Gould RJ. Glycosylated haemoglobin and glycosylated plasma proteins in the diagnosis of diabetes mellitus and impaired glucose tolerance. Diabetes Care 1984; 7: 147-150.
22. Kadowaki T, Miyale Y, Hagura R, Akanuma Y, Kajinuma H, Kuzuya N, et al. Risk factors for worsening to diabetes subjects with impaired glucose tolerance. Diabetologia 1984; 26: 44-49.
23. Marshall JA, Hoag S, Shetterly S, Hamman RF. Dietary fat predicts conversion from impaired glucose tolerance to NIDDM. Diabetes Care 1994; 16: 50-55.
24. Lauterberg BH, Smith CV, Mitchell JR. Regulation of hepatic glutathione homeostasis. In: Mitchell JR, Horning MG, eds. Drug Metabolism and Drug Toxicity. New York: Raven Press, 1984: 321-330.
25. Nicotera P, Orrenius S. Role of thiols in protection against biological reactive intermediates. Adv Exp Med Biol 1986; 187: 41-51.
26. Niki E. Interaction of ascorbate and α-tocopherol. Ann NY Acad Sci 1987; 498: 186-199.